#United States #San Francisco #Bio-Techne #Conference #Health Care

Bio-Techne Corporation to Present at BofA Securities 2025 Health Care Conference

Bio-Techne Corporation, a prominent player in the global life sciences sector, has announced its participation in the highly anticipated BofA Securities 2025 Health Care Conference. The event is scheduled for Tuesday, May 13, 2025, at 10:40 AM PDT, where Kim Kelderman, the President and Chief Executive Officer, will deliver a presentation showcasing the company's latest innovations. This presentation will be accessible via a live webcast on the Investor Relations page of Bio-Techne’s website.

Bio-Techne has gained a reputation for providing cutting-edge tools and bioactive reagents that serve the research and clinical diagnostic communities. With a portfolio boasting hundreds of thousands of products, the company plays a crucial role in facilitating scientific investigations into biological processes as well as understanding specific diseases. Their offerings are pivotal for drug discovery and contribute significantly to accurate clinical testing and diagnoses.

In fiscal year 2024, Bio-Techne generated approximately $1.2 billion in net sales, underscoring its stature in the life sciences industry. Furthermore, the company employs over 3,100 individuals worldwide, reflecting its commitment to innovation and excellence in scientific research and product development.

As the health care landscape continues to evolve, events like the BofA Securities Conference are essential for industry leaders to display their advancements and establish connections with stakeholders. Kim Kelderman’s presence signifies Bio-Techne's effort to remain at the forefront of the industry by engaging with investors and consumers alike.

To access the live webcast of the presentation, interested parties can visit the IR Calendar page of Bio-Techne’s Investor Relations website prior to the event. In this digital age, such webcasts allow broader access to key presentations, ensuring crucial information reaches a diverse audience.

Furthermore, Bio-Techne continuously emphasizes staying connected with its audience through various social media platforms, including Facebook, LinkedIn, Twitter, and YouTube. These channels provide insights into the company’s operations and developments in real-time, fostering a community of engaged stakeholders and enthusiasts in the life sciences field.

In summary, Bio-Techne’s presentation at the BofA Securities 2025 Health Care Conference is a notable event that highlights the company's ongoing commitment to innovation and leadership in life sciences. The company's robust portfolio and dedication to advancing scientific knowledge make it a compelling participant in this significant industry event.

For further updates on Bio-Techne and its innovations in the life sciences sector, visit Bio-Techne and join the conversation on their social media platforms.